SEC issues subpoena to Ocular Therapeutix over eye pain drug Ruby Khatun Khatun28 Dec 2017 9:30 AM ISTOcular Therapeutix Inc said the U.S. Securities and Exchange Commission (SEC) had issued a subpoena seeking information about the company’s eye-pain...
Anti-cancer injection launched by Dr Reddy's Ruby Khatun Khatun27 Dec 2017 10:03 AM ISTHYDERABAD: Dr Reddy's Laboratories said it has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran...
Herbalife Niteworks launched for cardiovascular health in India Ruby Khatun Khatun27 Dec 2017 9:45 AM ISTBangalore: In an effort to help consumers live happier and healthier lives by helping them care for their heart, Herbalife, a global nutrition...
USFDA cuts down on repeated reviews of medical devices Ruby Khatun Khatun27 Dec 2017 9:30 AM ISTThe U.S. Food and Drug Administration said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis...
Kmart settles drug overbilling allegations for 32 million dollars Ruby Khatun Khatun27 Dec 2017 9:15 AM ISTWASHINGTON: Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report...
ED attaches Delhi businessman property in Sterling Biotech money laundering case Ruby Khatun Khatun26 Dec 2017 10:45 AM ISTNew Delhi: The Enforcement Directorate (ED) on Sunday filed prosecution complaints against Delhi businessman, Gagan Dhawan, and also attached assets...
Fab India eyes Rs 500 crore turnover in organic products Ruby Khatun Khatun26 Dec 2017 10:30 AM ISTNew Delhi: Fab India controlled health and wellness brand Organic India is eyeing over Rs 500 crore turnover by the end of fiscal 2020 with the demand...
FDA granted priority review to Novartis for combo therapy for melanoma Ruby Khatun Khatun26 Dec 2017 10:15 AM ISTZURICH: The U.S. Food and Drug Administration has granted priority review for Novartis’s Tafinlar in combination with Mekinist for treating some...
FDA approves oral test for growth hormone deficiency: Aeterna Ruby Khatun Khatun26 Dec 2017 10:00 AM ISTCanada’s Aeterna Zentaris Inc said on Wednesday the U.S. Food and Drug Administration (FDA) has approved its oral test to diagnose adult growth...
Mesoblast's cell therapy for heart failure on fast track: FDA Ruby Khatun Khatun26 Dec 2017 9:45 AM ISTAustralian drug developer Mesoblast Ltd said the U.S. Food and Drug Administration would fast-track the review of its cell therapy treatment for heart...
Pharmacy chain in talks to buy Teva Pharm plant: source Ruby Khatun Khatun26 Dec 2017 9:30 AM ISTTEL AVIV: Israel’s largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Pharmaceutical Industries’ plant in the coastal city of...
FDA rejects Agile's contraceptive patch Ruby Khatun Khatun26 Dec 2017 9:15 AM ISTAgile Therapeutics Inc said the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug...
